Bournemouth University Faculty of Management colleagues Dr Emma Pullen and Professor Michael Silk, and Faculty of Media and Communication colleagues, Dr Dan Jackson and Dr Richard Scullion will be making headlines at the International Communication Association (ICA) annual conference (Sports Communication Division) in May 2018. They are being awarded the prestigious ICA best paper prize.
The paper is based on early findings from the Arts and Humanities Research Council funded project (grant ref: AH/P003842/1) on the cultural legacy of the 2016 Rio Paralympics. It is the first study of its kind to explore the mediation of para-sport broadcasting by highlighting the production decisions taken by the UK’s official Paralympic Broadcaster and the impact on audience perceptions and attitudes toward disability. Alongside academic outputs, the findings will be also translated into a number of creative artworks and a documentary film available to the public toward the end of the project.
Keep up to date with our progress via our project website www.pasccal.com, twitter:@pasccalproject, and the BU research blog.
Bournemouth University researchers awarded major new research council grant to explore Paralympic coverage
Psychology PGR Sarah Hodge presents at two prestigious USA conferences and wins prize
Photo of the Week: Riding for gold- 2016 Paralympic Games Prosthetic Limb Development










New HIV paper by BU PhD student
BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease